ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies

BKA Dayyeh, N Kumar, SA Edmundowicz… - Gastrointestinal …, 2015 - giejournal.org
The increasing global burden of obesity and its associated comorbidities has created an
urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric …

Bariatric and metabolic surgery: a shift in eligibility and success criteria

G Frühbeck - Nature Reviews Endocrinology, 2015 - nature.com
The obesity epidemic, combined with the lack of available and effective treatments for
morbid obesity, is a scientific and public health priority. Worldwide, bariatric and metabolic …

Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery

S Madsbad, C Dirksen, JJ Holst - The lancet Diabetes & …, 2014 - thelancet.com
Bariatric surgery is the most effective treatment for obesity and also greatly improves
glycaemic control, often within days after surgery, independently of weight loss …

Effect of the duodenal-jejunal bypass liner on glycemic control in patients with type 2 diabetes with obesity: a meta-analysis with secondary analysis on weight loss …

P Jirapinyo, AV Haas, CC Thompson - Diabetes care, 2018 - Am Diabetes Assoc
OBJECTIVE Duodenal-jejunal bypass liner (DJBL) is an endoscopic device that may mimic
small bowel mechanisms of Roux-en-Y gastric bypass (RYGB). Previous studies have …

ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies

ABET Force, BKA Dayyeh, N Kumar… - Gastrointestinal …, 2015 - pubmed.ncbi.nlm.nih.gov
The increasing global burden of obesity and its associated comorbidities has created an
urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric …

The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial

P Koehestanie, C de Jonge, FJ Berends, IM Janssen… - 2014 - journals.lww.com
Objective: Investigate the safety and efficacy of 6 months' duodenal-jejunal bypass liner
(DJBL) treatment in comparison with dietary intervention for obesity and type 2 diabetes …

Endoscopic bariatric therapies

BKA Dayyeh, SA Edmundowicz… - Gastrointestinal …, 2015 - giejournal.org
BACKGROUND More than one-third of US adults are obese. 1 The increasing prevalence of
obesity in the United States has been accompanied by an increasing prevalence in its …

Recent advances in clinical practice challenges and opportunities in the management of obesity

A Acosta, BKA Dayyeh, JD Port, M Camilleri - Gut, 2014 - gut.bmj.com
Despite advances in understanding the roles of adiposity, food intake, GI and adipocyte-
related hormones, inflammatory mediators, the gut–brain axis and the hypothalamic nervous …

Therapeutic luminal coating of the intestine

Y Lee, TE Deelman, K Chen, DSY Lin, A Tavakkoli… - Nature Materials, 2018 - nature.com
The gastrointestinal tract is the site of most drug delivery and therapeutic interventions for
the management and treatment of numerous diseases. However, selective access to its …

Endobarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism

N Vilarrasa, AGR de Gordejuela, A Casajoana… - Obesity surgery, 2017 - Springer
Background The purpose of this study was to evaluate the efficacy and safety of
Endobarrier® in grade 1 obese T2DM patients with poor metabolic control and the role of …